Because CD7neg HTLV-1-infected cells have a significant potential of ATL progression, examining the CADM1+ CD7neg predominant pattern in HTLV-1-positive RA patients may be a predictive finding of ATL development. This evidence concerns the gene CADM1 and rheumatoid arthritis.